Decreased secretin and glucagon responsiveness of adenylate cyclase in cardiac membranes from hypothyroid rats  by Robberecht, Patrick et al.
Volume 132, number 1 FEBS LETTERS September 1981 
DECREASED SECRET IN  AND GLUCAGON RESPONSIVENESS OF  ADENYLATE CYCLASE 
IN CARDIAC MEMBRANES FROM HYPOTHYROID RATS 
Patrick ROBBERECHT, Roland POCHET +, Pierre CHATELAIN*, Alain VERLOES +, Jean-Claude CAMUS, 
Philippe DE NEEF and Jean CHRISTOPHEt 
Laboratory of Biological Chemistry and Nutrition and +Laboratory of Histology, Medical School, Universitd Libre de Bruxelles, 
rue Evers, 2, 1000 Brussels, Belgium 
Received 20 July 1981 
1. Introduction 
Thyroid hormones modulate cardiac activity and 
the number of adrenoceptors and muscarinic receptors 
in heart: in cardiac membranes from hypothyroid rats, 
there is a moderate decrease in 13-adrenoceptors [1,2], 
an increase in nmscarinic receptors [3], and a slight 
increase [4] or no change [1] in a-adrenoceptors, By
contrast, hyperthyroidism is characterized by an 
increase in the number of/3-adrenoceptors (quantified 
by [3H] dihydroalprenolol) [ 1,5 ] whereas the number 
ofmuscarinic receptors [3] and c~-adrenoceptors 
[1,2,6] decreases. 
No infornmtion is available on the incidence of the 
thyroid status on cardiac receptors to peptide hor- 
mones and peptide neuro-effectors. We have character- 
ized the presence of receptors pecific for secretin 
and the parent peptide VIP (vasoactive intestinal pep- 
tide) in rat heart membranes by the capacity of these 
peptides to stimulate adenylate cyclase activity in the 
presence of guanine nucleotides [7]. This receptor 
system is altered in congenitally hypertensive (SHR) 
[8,9] and obese (fa/fa) Zucker rats [10]. Since one of 
the clinical features in obese fa/fa rats is a mild hypo- 
thyroidism [11 ], we investigated here whether hypo- 
thyroidism induced by propylthiouracil (PTU) or 
surgical thyroidectomy could alter secretin-stimulated 
Abbreviations: Gpp [NH] p, guanosine 5'-(fl,'y-imido)triphos- 
phate; PTU, propylthiouracil; VIP, vasoactive intestinal pep- 
tide; Ta, triiodothyronine; Ds0, concentration required to 
exert half-maximal ctivation 
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adenylate cyclase activity in rat heart membranes. 
The stimulation of the same enzyme system with glu- 
cagon, isoproterenol, NaF and guanine nucleotides 
served as a reference. The results showed that hypo- 
thyroidism decreased the response of adenylate cyclase 
to secretin and glucagon, increased the response to 
NaF, and was without effect on the response to iso- 
proterenol and guanine nucleotides. 
2. Materials and methods 
Hypothyroidism was induced by 2 methods: 
(1) A batch of 10 male Wistar albino rats weighing 
80 + 5 g and 6 weeks old was used. Five of these ani- 
mals received 0.05% propylthiouracil (PTU) dissolved 
in drinking water for 8 weeks and the other 5 served 
as controls. Hypothyroidism was ascertained by reduced 
growth (body weight was 102 + 12 g only in PTU- 
treated rats as compared to 302 +- 8 g in control ani- 
mals, at .the time of sacrifice) and low levels of circu- 
lating T3 measured by a standard RIA (180 + 30 ng/1 
in tile serum of PTU-treated rats as compared to 
750 -+ 50 ng/l in control animals). 
(2) A group of 10 adult male Wistar albino rats 
315 + 9 g body wt was used. Five animals were sur- 
gically thyroidectomized under ether anesthesia nd 
sacrificed 10 days alter surgery: at that time the body 
weight was 308 -+ 7 g in thyroidectomized rats and 
358 +- 4 g in control animals, and the corresponding 
serum T3 values were 100 + 20 ng/1 and 750 -+ 50 ng/l. 
The animals were sacrificed by decapitation and the 
heart was carefully dissected out, rinsed at room tem- 
perature with isotonic NaC1, weighed and frozen in 
liquid nitrogen. A crude particulate fraction from heart 
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was prepared as in [7] and adenylate cyclase activity 
was determined as in [12]. Protein concentrat ion  was 
measured by the Lowry procedure,  using bovine serum 
albumin as a standard.  
Synthet ic  secretin was kindly supplied by Dr W. 
K6nig (Hoechst  Aktiengesel lschaft ,  F rankfur t ) ;  glu- 
cagon was supplied by Novo Industr i  (Etabl issement 
Couvreur,  Brussels). D,L- Isoproterenol ,  ATE  GTP, 
Gpp [NH] p and cyclic AMP were from Sigma Chemical 
Co. (St Louis MO); 4(6)-propyl-2-thiouraci l  (PTU) 
was from Koch-L ight Labs (Colnbrook) .  [c~-32P] ATP 
(15 C i /mmol )  and cyclic [8-3H]AMP (27 C i /mmol )  
were purchased from the Radiochemical  Centre 




The hypothyro id i sm achieved after PTU t reatment  
or thyro idectomy was demonst rated  by the low levels 
of  circulating T3 (see above). The values of  the param- 
eters of  adenylate cyclase activity in the 2 groups of  
control  rats were similar so that  these control  data 
were combined  in table 1 and fig.1,2. 
Basal, GTP- and Gpp [NH]p-act ivated cardiac aden- 
ylate cyclase activities were not  affected by hypothy-  
roidism (table 1). The Ds0 for Gpp[NH]p  activation 
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Fig.1. Dose- effect curves of adenylate cyclase activation by 
Gpp[NH]p in control (o o, n = 10), PTU-treated (A--A, 
n = 5), and thyroidectomized (o - -e ,  n = 5) rats. The results 
are expressed in pmol cyclic AMP produced over basal .
min -1 . mg membrane protein -~. 
Table 1 
Adenylate cyclase activity in cardiac membranes from control, PTU-treated, and 
thyroidectomized rats 
Addition(s) Control rats PTU-treated Thyroidectomized 
(n = 10) rats (n = 5) rats (n = 5) 
None 29± 3 35± 2 34± 2 
10 -s MGTP 36 -+ 3 37± 3 38± 3 
10 -4 M Gpp[NH]p 215 -+ 10 190 ± 16 221 ± 22 
10 -~ M NaF 371 + 28 572 -+ 36 a 503 ± 37 a 
10 -s M GTP + 
10 -4 M D,L-isoproterenol 127- + 8 144 ± 11 115 _+ 6 
10 -s M GTP + 
10 -5 Mglucagon 108± 7 75± 3 a 86 ± 8 
10 -5 M GTP+ 
3× 10 -6Msecretin 68± 7 24± 2 a 21± 2 a 
a Indicates values significantly different (p < 0.05) from values in corresponding controls, 
using the Student's t-test 
The data are expressed as pmol cyclic AMP formed, rain -1 . mg protein -I. Those with 
D,L-isoproterenol, glucagon, and secretin were obtained after subtracting the control 
value observed in the presence of 10 -s M GTP alone. Means ± SEM from 10 or 5 animals 
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Fig.2. Dose-effect curves of adenylate cyclase activation by D,L-isoproterenol (A), glucagon (B) and secietin (C) in control 
(0--% n = 10), PTU-treated (A--A, n = 5), and thyroidectomized (o--e,  n = 5) rats. The results are expressed in pmol cyclic 
AMP produced min -1 . mg membrane protein -1 over the unstimulated value obtained in the presence of 0.1 t~M GTP. 
increased by 54% in PTU-treated rats and by 36% in 
thyroidectomized rats (table 1). 
The stimuli acting through membrane receptors 
were tested in the presence of 10 -s M GTP, since they 
were inefficient otherwise [7]. In both PTU-treated 
and thyroidectomized rats the maximal response to 
D,L-isoproterenol and the corresponding Dso of stim- 
ulation were unaffected when compared to the con- 
trol group (table 1, fig.2). A significant decrease in 
maximal glucagon stimulation was observed in PTU- 
treated and thyroidectomized rats but the Ds0 for 
giucagon remained normal (table 1, fig.2). The maxi- 
mal response to secretin was the most severely im- 
paired by hypothyroidism (by 63% and 68%, respec- 
tively, in PTU-treated and thyroidectomized rats) 
with, again, no change in the Dso for secretin (table 1, 
fig .2). 
adenylate cyclase activity (fig.2), These effects were 
observed as early as 10 days after tbyroidectomy in
the second experiment. In line with these data, reduced 
glucagon-stimulated adenylate cyclase activity has been 
reported in fat cells [ 13] and liver membranes together 
with a lower density of glucagon receptors in liver 
membranes [14] in thyroidectomized rats. The latter 
result was, however, not confirmed in [ 15]. Here, the 
alterations due to hypothyroidism were even more 
striking for secretin than for glucagon. It is tempting, 
therefore, to suggest hat secretin receptors in heart 
are especially responsive to the levels of circulating 
thyroid hormones. The possible relationship between 
the altered secretin- and glucagon-stimulated adenylate 
cyclase activity and various cardiac symptoms observed 
in hypothyroid patients, such as bradycardia nd dimin- 
ished cardiac output, remains to be established [16]. 
4. Discussion 
Two clear results emerged from our study: 
(1) Hypothyroidism in male Wistar rats induced a 
decrease in secretin- and glucagon-stimulated cardiac 
(2) NaF-stimulated adenylate cyclase activity 
increased significantly in cardiac membranes from 
hypothyroid rats, while Gpp [NH] p- and isoproterenol- 
stimulations remained normal over the entire dose-  
effect curves (fig.1,2). These data suggest hat hypo- 
thyroidism was unable to influence the coupling 
mechanism involving the guanine nucleotide regulatory 
35 
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protein of the adenylate cyclase system (the G-protein 
also known as G/F, G or N). They were in clear con- 
tradiction with those in [17] where a sharp decrease 
in Gpp [NH]p-stimulation f adenylate cyclase and in 
the number of/3-adrenoceptors in the heart of rats 
suffering from prolonged hypothyroidism was shown. 
The same problem has been investigated in adipose 
tissue and liver from hypothyroid animals [18,19]. It 
was observed that several properties of the guanine 
nucleotide regulatory protein and the number of 
/3-adrenoceptors remained nonnal in fat cells but that 
isoproterenol-stimulation of adenylate cyclase was 
sharply reduced. In liver cells, the situation was dif- 
ferent: isoproterenol-stimulated denylate cyclase was 
increased and GTP could not norma]ly reduce the aftin- 
ity of/3-adrenoceptors for their ligands. Here, when 
the normal response of cardiac adenylate cyclase to 
Gpp [NH] p and D,L-isoproterenol is confronted with 
the high NaF sensitivity of the enzyme system, there 
was no indication of an effect of hypothyroidism on 
cardiac/3-adrenergic re eptors and it is clear that the 
situation of guanine nucleotide regulatory protein(s) 
warrants further study by a more direct approach. 
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